A Study of NT 201 Doses in the Treatment of Platysma Prominence
Public ClinicalTrials.gov record NCT05773053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 Doses in the Treatment of Platysma Prominence
Study identification
- NCT ID
- NCT05773053
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merz Aesthetics GmbH
- Industry
- Enrollment
- 73 participants
Conditions and interventions
Conditions
Interventions
- NT 201 Drug
- NT 201 Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 21, 2023
- Primary completion
- Oct 18, 2023
- Completion
- Jan 23, 2024
- Last update posted
- Oct 20, 2024
2023 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Merz Investigation Site #0010170 | Washington D.C. | District of Columbia | 20037 | — |
| Merz Investigational Site #0010453 | Aventura | Florida | 33180 | — |
| Merz Investigation Site #0010470 | Coral Gables | Florida | 33143 | — |
| Merz Investigation Site #0010105 | Metairie | Louisiana | 70006 | — |
| Merz Investigation Site #0010471 | Verona | New Jersey | 07044 | — |
| Merz Investigation Site #0010469 | New York | New York | 10022 | — |
| Merz Investigation Site #0010405 | New York | New York | 10028 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05773053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05773053 live on ClinicalTrials.gov.